JP2016522406A5 - - Google Patents

Download PDF

Info

Publication number
JP2016522406A5
JP2016522406A5 JP2016513253A JP2016513253A JP2016522406A5 JP 2016522406 A5 JP2016522406 A5 JP 2016522406A5 JP 2016513253 A JP2016513253 A JP 2016513253A JP 2016513253 A JP2016513253 A JP 2016513253A JP 2016522406 A5 JP2016522406 A5 JP 2016522406A5
Authority
JP
Japan
Prior art keywords
biomarker
subject
pick disease
level
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016513253A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016522406A (ja
JP6660291B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2014/001306 external-priority patent/WO2014183873A1/en
Publication of JP2016522406A publication Critical patent/JP2016522406A/ja
Publication of JP2016522406A5 publication Critical patent/JP2016522406A5/ja
Priority to JP2020019691A priority Critical patent/JP6989636B2/ja
Application granted granted Critical
Publication of JP6660291B2 publication Critical patent/JP6660291B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016513253A 2013-05-14 2014-05-14 ニーマン・ピック病の診断のための方法 Expired - Fee Related JP6660291B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2020019691A JP6989636B2 (ja) 2013-05-14 2020-02-07 ニーマン・ピック病の診断のための方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13002515 2013-05-14
EP13002515.8 2013-05-14
PCT/EP2014/001306 WO2014183873A1 (en) 2013-05-14 2014-05-14 Method for the diagnosis of niemann-pick disease

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020019691A Division JP6989636B2 (ja) 2013-05-14 2020-02-07 ニーマン・ピック病の診断のための方法

Publications (3)

Publication Number Publication Date
JP2016522406A JP2016522406A (ja) 2016-07-28
JP2016522406A5 true JP2016522406A5 (https=) 2017-06-08
JP6660291B2 JP6660291B2 (ja) 2020-03-11

Family

ID=48428310

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016513253A Expired - Fee Related JP6660291B2 (ja) 2013-05-14 2014-05-14 ニーマン・ピック病の診断のための方法
JP2020019691A Expired - Fee Related JP6989636B2 (ja) 2013-05-14 2020-02-07 ニーマン・ピック病の診断のための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020019691A Expired - Fee Related JP6989636B2 (ja) 2013-05-14 2020-02-07 ニーマン・ピック病の診断のための方法

Country Status (10)

Country Link
US (1) US10302664B2 (https=)
EP (1) EP2997384B1 (https=)
JP (2) JP6660291B2 (https=)
CA (1) CA2912274A1 (https=)
CY (1) CY1121790T1 (https=)
DK (1) DK2997384T3 (https=)
ES (1) ES2731920T3 (https=)
SA (1) SA515370129B1 (https=)
TR (1) TR201906195T4 (https=)
WO (1) WO2014183873A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3004896T (lt) * 2013-06-07 2020-01-10 Genzyme Corporation Rūgštinės sfingomielinazės sutrikimų žymuo ir jo panaudojimas
CA2967504A1 (en) * 2014-11-19 2016-05-26 Centogene Ag Method for the diagnosis of niemann-pick disease using a biomarker
WO2020010305A1 (en) 2018-07-05 2020-01-09 The Board Of Regents Of The University Of Oklahoma Gene signatures for cancer characterization and methods of use
EP3976218B1 (en) * 2019-05-31 2025-02-19 Genzyme Corporation Two-dimensional lc-ms/ms systems

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9908190D0 (en) * 1999-04-09 1999-06-02 Pharming Intellectual Pty Bv Diagnosis of lysosomal storage disorders using saposins and other markers
GB0128498D0 (en) * 2001-11-28 2002-01-23 Inst Of Child Health International standards for sphingolipids
ATE550664T1 (de) * 2003-03-31 2012-04-15 Womens & Childrens Hospital Multiplex-screening auf lysosomale speicherkrankheiten (lsds)
JP2007514661A (ja) * 2003-11-25 2007-06-07 マウント シナイ スクール オブ メディスン オブ ニューヨーク ユニバーシティー ニーマンピック病のシャペロンに基づく治療方法
CN101454331A (zh) * 2006-03-24 2009-06-10 菲诺梅诺米发现公司 有效用于诊断前列腺癌的生物标记，及其方法
US8497122B2 (en) * 2008-04-11 2013-07-30 Washington University Biomarkers for Niemann-pick C disease and related disorders
US8313949B2 (en) * 2009-04-16 2012-11-20 Nextcea Inc. Detecting phospholipidosis and diagnosing lysosomal storage disorders
SI3998078T1 (sl) * 2009-08-28 2026-02-27 Genzyme Corporation Encimsko nadomestno zdravljenje z naraščajočim odmerkom za zdravljenje pomanjkanja kisle sfingomielinaze

Similar Documents

Publication Publication Date Title
JP5212893B2 (ja) Ｎ結合型糖鎖を利用した膵臓癌の診断方法
JP2014533367A5 (https=)
Such-Sanmartín et al. Targeted mass spectrometry analysis of the proteins IGF1, IGF2, IBP2, IBP3 and A2GL by blood protein precipitation
JP6678046B2 (ja) 質量分析によるサイログロブリン定量
JP2022071119A (ja) 肺癌を検出するためのバイオマーカーパネル
US20140332682A1 (en) Methods of detecting reverse triiodothyronine by mass spectrometry
JP2016522406A5 (https=)
Nys et al. Enhancing protein discoverability by data independent acquisition assisted by ion mobility mass spectrometry
CN102348982B (zh) 肌变性疾病的检测方法以及治疗效果判定方法
CN113164627A (zh) 治疗和监测颗粒体蛋白前体相关病症的方法
WO2018007422A1 (en) Identification of human non-alcoholic fatty liver disease (nafld) subtypes
WO2020104458A1 (en) Methods and kits for detecting liver dysfunction in a subject
US20190345551A1 (en) METHOD FOR DETECTING MITOCHONDRIAL tRAN MODIFICATION
WO2014049282A1 (fr) Procede pour le diagnostic de dystrophies musculaires
JP2025172848A (ja) マススペクトロメトリーによるアポリポタンパク質ｅアイソタイプの検出
ES2839514T3 (es) Métodos de diagnóstico basados en perfiles de lípidos
JP2020064051A (ja) 神経変性疾患の診断用ペプチドマーカー
JP2017538927A5 (https=)
WO2006108051A2 (en) Compositions and methods relating to alzheimer's disease
CN112305120B (zh) 代谢物在动脉粥样硬化性脑梗死中的应用
WO2021222109A1 (en) Methods of detecting ube3a protein
CN114200056B (zh) 用于预测进展期白癜风对激素治疗敏感性的生物标志物及其应用
CN112599240B (zh) 代谢物在脑梗死中的应用
Krishnan et al. Nanostructured Silicon Enabled HR-MS for the Label-Free Detection of Biomarkers in Colorectal Cancer Plasma Small Extracellular Vesicles. J. Nanotheranostics 2022, 3, 189–202
HK40089947A (en) Methods for quantification of amyloid beta peptides in plasma by mass spectrometry